Isaak Ailts
University of North Dakota(US)Mayo Clinic Hospital(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial(2023)129 cited
- → Post-Injury and Resolution Response to Repetitive Inhalation Exposure to Agricultural Organic Dust in Mice(2017)26 cited
- → Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial(2022)4 cited
- → Abstract P056: Germline cancer susceptibility gene testing in unselected patients with soft tissue sarcoma: a multi-center prospective study(2023)2 cited
- Biopsychosocial Pain Management and its Effect on Postoperative Opioid Use.(2020)
- → The evolution of clinical outcomes in metastatic pancreatic adenocarcinoma: a 10-year experience at a tertiary referral center(2022)2 cited
- → Correlation of Quality of Life between Treatment Outcomes in the Majic Study Which Compared Ruxolitinib to Best Available Therapy in Polycythemia Vera(2021)1 cited
- → Evolution of clinical outcomes of metastatic pancreatic adenocarcinoma: A 10-year single-institution retrospective study.(2020)
- → Exploring Genotype:Phenotype Correlations at Baseline and at One Year for ET and PV Patients in the Majic Study(2021)
- → EVOLVE: Evaluating the Safety of and Quality of Life in De-escalated Head and Neck Irradiation in HPV + Oropharynx Cancer in Non/Minimal Smokers in the Community Setting(2024)